About HCS Lab

A joint venture between University of Turku & Turku Science Park

HCS Lab offers a unique phenotypic screening pipeline, specifically tailored for the needs in early stage drug discovery. Our organotypic cell models specifically address the complex biology of human tissues, and recapitulate histology and morphologic features in high-throughput. We offer expert services based on high-content imaging, specialized on cancer invasion and tumor-stroma interactions. Apart from epithelial tumor cell lines, we work with primary, patient-derived cells.

HCS Lab team in autumn 2016